Dixon CJ, Bowler WB, Fleetwood P, Ginty AF, Gallagher JA, Carron JA.(1997)
Extracellular nucleotides stimulate proliferation in MCF-7 breast cancer
cells via P2 purinoceptors. Brit. J. Cancer 75 34-39.
Nucleotides such as ATP can act as extracellular effector molecules by
interaction with specific cellular receptors known as P2 purinoceptors.
Recently, we cloned the human P2U purinoceptor from osteoclastoma and
demonstrated its expression in skeletal tissues. In the current study we
have investigated the expression of P2U purinoceptors in human breast tumour
cell lines and examined functional effects of extracellular nucleotides on
these cells. By reverse transcription-linked polymerase chain reaction
RT-PCR) the expression of mRNA for P2U purinoceptors was demonstrated in four
human breast cancer cell lines, Hs578T, MCF-7, SK-Br3 and T47-D. In MCF-7
cells, extracellular ATP (1-100 m M) elevated intracellular free calcium
concentration [Ca2+]i, indicating that these cells express functional
P2 purinoceptors. UTP elevated [Ca2+]i in an identical manner to ATP,
whereas 2-methylthioATP was completely ineffective, and ADP only partially
effective. This pharmacological profile suggests that the P2 subtype may be
the only P2 purinoceptor expressed by these cells. The functional
significance of P2U purinoceptor expression by MCF-7 cells was investigated
by analysing the effects of extracellular ATP on cell proliferation. The
slowly hydrolysed analogue of ATP, ATP gamma S (which was also shown to
elevate [Ca2+]i), induced proliferation of MCF-7 cells when added daily to
serum-free cultures over a period of 3 days. ASP gamma S-induced proliferation
was demonstrated by three separate methods, detection by scintillation
counting of 3H-thymidine incorporation, immunocytochemical detection of
5-bromo-2-deoxyuridine incorporation and direct counting or cell numbers.
These data suggest that ATP, possibly released at sites of tissue injury or
inflammation, may be capable of growth factor action in promotion of tumour
proliferation or progression.
Return to.....
Papers from the human bone cell research group
HBCRG homepage